icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
Dual therapy with Lopinavir/ Ritonavir (LPV/r) and Lamivudine (3TC) is non-inferior to standard triple drug therapy in Na´ve HIV-1 infected subjects : 48-week results of the GARDEL Study.
 
 
  Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
 
Pedro Cahn on behalf of the GARDEL study group

0227181

0227182

0227183

0227184

0227185

0227186

0227187

0227188

0227189

02271810

02271811

02271812

02271813

02271814

02271815

02271816

02271817